======= NPRL3 ======= == Gene Information == * **Official Symbol**: NPRL3 * **Official Name**: NPR3 like, GATOR1 complex subunit * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8131|8131]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q12980|Q12980]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NPRL3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NPRL3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600928|Open OMIM]] == Function Summary == * **Entrez Summary**: The function of the encoded protein is not known. [provided by RefSeq, Aug 2011]. * **UniProt Summary**: As a component of the GATOR1 complex functions as an inhibitor of the amino acid-sensing branch of the TORC1 pathway. The GATOR1 complex strongly increases GTP hydrolysis by RRAGA and RRAGB within RRAGC-containing heterodimers, thereby deactivating RRAGs, releasing mTORC1 from lysosomal surface and inhibiting mTORC1 signaling. The GATOR1 complex is negatively regulated by GATOR2 the other GATOR subcomplex in this amino acid-sensing branch of the TORC1 pathway. {ECO:0000269|PubMed:23723238}. |NPR3| |GATOR1 complex| |TORC1 signaling| |aorta morphogenesis| |TOR signaling| |regulation of autophagosome assembly| |regulation of vacuole organization| |cellular response to amino acid starvation| |response to amino acid starvation| |negative regulation of TOR signaling| |aorta development| |artery morphogenesis| |ventricular septum development| |artery development| |roof of mouth development| |regulation of TOR signaling| |cardiac septum development| |cardiac ventricle development| |cellular response to starvation| |cardiac muscle tissue development| |cardiac chamber development| |regulation of macroautophagy| |response to starvation| |regulation of organelle assembly| |cellular response to nutrient levels| |cellular response to extracellular stimulus| |GTPase activator activity| |striated muscle tissue development| |muscle tissue development| |lysosomal membrane| |regulation of autophagy| |cellular response to external stimulus| |blood vessel morphogenesis| |positive regulation of GTPase activity| |regulation of GTPase activity| |blood vessel development| |response to nutrient levels| |negative regulation of intracellular signal transduction| |vasculature development| |cardiovascular system development| |heart development| |response to extracellular stimulus| |tube morphogenesis| |positive regulation of hydrolase activity| |regulation of cellular catabolic process| |tube development| |circulatory system development| |regulation of cellular component biogenesis| |regulation of catabolic process| |negative regulation of signal transduction| |regulation of hydrolase activity| |regulation of organelle organization| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of catalytic activity| |negative regulation of response to stimulus| |intracellular signal transduction| |cellular response to stress| |tissue development| |positive regulation of molecular function| |regulation of intracellular signal transduction| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|-4.93| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|-4.35| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-4.03| |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|-3.71| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-3.56| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|-3.54| |[[:results:exp515|PU-H71 1μM R08 exp515]]|-3.4| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|-3.39| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-3.36| |[[:results:exp474|CR131-b 0.005μM R08 exp474]]|-3.35| |[[:results:exp180|Dynasore 10μM R04 exp180]]|-3.34| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|-3.2| |[[:results:exp245|UM0011500 5μM R05 exp245]]|-3| |[[:results:exp436|Dynasore 7μM R08 exp436]]|-2.99| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|-2.98| |[[:results:exp159|Docetaxel 0.001 to 0.002μM on day4 R04 exp159]]|-2.97| |[[:results:exp517|Quercetin 20μM R08 exp517]]|-2.96| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|-2.93| |[[:results:exp67|BVD-523 15μM R02 exp67]]|-2.92| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|-2.82| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|-2.82| |[[:results:exp5|Alpha-Amanitin 0.5μM R00 exp5]]|-2.75| |[[:results:exp8|Brefeldin A 0.02μM R00 exp8]]|-2.74| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-2.7| |[[:results:exp326|CCT251545 20μM R07 exp326]]|-2.66| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|-2.6| |[[:results:exp81|Selumetinib 20μM R02 exp81]]|-2.58| |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|-2.57| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|-2.54| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|-2.54| |[[:results:exp360|Genistein 15μM R07 exp360]]|-2.53| |[[:results:exp340|BN82002 4μM R07 exp340]]|-2.51| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-2.48| |[[:results:exp32|Rifampicin 10μM R00 exp32]]|-2.47| |[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|-2.45| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|-2.42| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|-2.4| |[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|-2.39| |[[:results:exp107|UMK57 0.6μM R03 exp107]]|-2.36| |[[:results:exp243|S-trityl-L-cysteine 0.5μM R05 exp243]]|-2.33| |[[:results:exp246|UM0011500 10μM R05 exp246]]|-2.32| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|-2.32| |[[:results:exp79|Q15 2.7μM R02 exp79]]|-2.31| |[[:results:exp457|Bisphenol F 50μM R08 exp457]]|-2.3| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|-2.26| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|-2.23| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-2.23| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-2.22| |[[:results:exp443|SNS-032 15μM R08 exp443]]|-2.22| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-2.18| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-2.18| |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|-2.16| |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|-2.15| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|-2.14| |[[:results:exp23|Nocodazole 0.02μM R00 exp23]]|-2.11| |[[:results:exp232|Epothilone-D 0.004 to 0.006μM on day4 R05 exp232]]|-2.1| |[[:results:exp406|Thalidomide 20μM R07 exp406]]|-2.1| |[[:results:exp219|A-395N 10μM R05 exp219]]|-2.08| |[[:results:exp379|MSC2530818 10μM R07 exp379]]|-2.08| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|-2.07| |[[:results:exp275|Citral 75μM R06 exp275]]|-2.07| |[[:results:exp59|UMK57 1μM R01 exp59]]|-2.03| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|-2.02| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|-2| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|-1.98| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|-1.96| |[[:results:exp346|CoCl2 18μM R07 exp346]]|-1.95| |[[:results:exp375|Lenalidomide 20μM R07 exp375]]|-1.94| |[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|-1.94| |[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|-1.93| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|-1.91| |[[:results:exp503|Mitomycin-C 0.06μM R08 exp503]]|-1.91| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|-1.9| |[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|-1.89| |[[:results:exp446|4-Nitroquinoline-1-oxide 0.5μM R08 exp446]]|-1.88| |[[:results:exp290|LLY-283 2.6μM R06 exp290]]|-1.88| |[[:results:exp33|Rotenone 2μM R00 exp33]]|-1.88| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|-1.85| |[[:results:exp430|Rifampicin 30μM R08 exp430]]|-1.83| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|-1.8| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|-1.8| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-1.76| |[[:results:exp333|All-trans-Retinoic-Acid 8μM R07 exp333]]|-1.74| |[[:results:exp169|BH1 1μM R04 exp169]]|-1.74| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|-1.73| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|-1.73| |[[:results:exp263|Aphidicolin 0.04μM R06 exp263]]|1.73| |[[:results:exp483|FTY720 3μM R08 exp483]]|1.75| |[[:results:exp218|A-395 10μM R05 exp218]]|1.76| |[[:results:exp330|5-Azacytidine 2μM R07 exp330]]|1.93| |[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|1.94| |[[:results:exp150|SGC0649 7μM R03 exp150]]|1.95| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|1.95| |[[:results:exp124|GSK343 3μM R03 exp124]]|2| |[[:results:exp508|NN-Dimethylsphingosine 2.5μM R08 exp508]]|2.02| |[[:results:exp530|Thioridazine 5μM R08 exp530]]|2.04| |[[:results:exp155|UNC1999 2μM R03 exp155]]|2.18| |[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|2.24| |[[:results:exp151|SGC0946 7μM R03 exp151]]|2.42| |[[:results:exp534|Trientine 500μM R08 exp534]]|2.68| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|2.78| |[[:results:exp389|PF-06409577 20μM R07 exp389]]|2.93| |[[:results:exp189|Temozolomide 200μM R04 exp189]]|2.97| |[[:results:exp216|Erlotinib 10μM R05 exp216]]|3.01| |[[:results:exp452|Azithromycin 100μM R08 exp452]]|3.1| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|3.14| |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|3.28| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|3.34| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|4.2| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|4.26| |[[:results:exp485|GSK626616 14μM R08 exp485]]|5.56| |[[:results:exp504|MK2206 4μM R08 exp504]]|7.53| ^Gene^Correlation^ |[[:human genes:n:nprl2|NPRL2]]|0.849| |[[:human genes:d:depdc5|DEPDC5]]|0.839| |[[:human genes:s:szt2|SZT2]]|0.826| |[[:human genes:k:kptn|KPTN]]|0.729| |[[:human genes:i:itfg2|ITFG2]]|0.722| |[[:human genes:c:c12orf66|C12orf66]]|0.713| |[[:human genes:s:sesn2|SESN2]]|0.656| |[[:human genes:t:tsc2|TSC2]]|0.653| |[[:human genes:t:tsc1|TSC1]]|0.627| |[[:human genes:c:ccdc130|CCDC130]]|0.473| |[[:human genes:z:zfp36l2|ZFP36L2]]|0.445| |[[:human genes:p:prkaa1|PRKAA1]]|0.411| |[[:human genes:a:anp32a|ANP32A]]|0.409| |[[:human genes:h:hexim1|HEXIM1]]|0.402| Global Fraction of Cell Lines Where Essential: N/A ^Tissue^Fraction Of Cell Lines Where Essential^ == Essentiality in NALM6 == * **Essentiality Rank**: 14613 * **Expression level (log2 read counts)**: 5.36 {{:chemogenomics:nalm6 dist.png?nolink |}}